Research Projects

Breast Cancer Progression Associated with Hypercoagulation and Chronic Inflammation

Breast Cancer Progression Associated with Hypercoagulation and Chronic Inflammation

Dr Janette Bester

Dr Janette Bester

Title of the project

Breast Cancer progression associated with hypercoagulation and chronic inflammation.

Project Description

To date, cancer remains one of the leading causes of death around the world. Of interest in this study is breast cancer, which is characterised by uncontrolled tumour growth in breast tissue. The most commonly diagnosed form of cancer in women world-wide, breast cancer affects women from all ethnic backgrounds and cultures, although higher incidence rates do occur in more developed countries. Due to the nature of breast tissue and the integrated role of hormonal pathways and cell growth mechanisms, breast cancer is complex and difficult to treat. It is well documented that breast cancer results in a hypercoagulable state in affected patients, resulting from the increased inflammatory response responding to, or resulting from the presence of the cancer.

This hypercoagulable state affects many of the body’s systems, most notably, the haemostatic system. This system is especially sensitive to inflammation leading to hypercoagulation, thus it is not unexpected to note that thrombosis associated conditions are major complications in breast cancer patients. Notable changes in the vascular system under inflammatory and hypercoagulable conditions will be investigated which include changes to erythrocytes and the viscoelastic properties of the clotting mechanism of the body.

This study aims to investigate the effect of breast-cancer associated inflammation by examining these key characteristics of the vascular system, in order to obtain further insight into the changes, which occur within these patients. These insights may provide new opportunities for better monitoring of the progression of the disease as well as a better understanding of the role played by inflammation and hypercoagulation, possibly opening opportunities for improving the prognosis of the disease by removing thrombotic-related conditions as a major complication.


« BACK


Do you have a question?